PML anticorps (AA 59-239)
Aperçu rapide pour PML anticorps (AA 59-239) (ABIN7625406)
Antigène
Voir toutes PML AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 59-239
-
Fonction
- Promyelocytic Leukemia Protein (PML) Polyclonal Antibody
-
Séquence
- Gln59~Glu239
-
Attributs du produit
- The Promyelocytic Leukemia Protein (PML) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
-
Purification
- Antigen-specific affinity chromatography followed by Protein A affinity chromatography
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5 mg/mL
-
Buffer
- PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- 2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
-
Date de péremption
- 12 months
-
-
- PML (Promyelocytic Leukemia (PML))
-
Autre désignation
- PML
-
ID gène
- 5371
-
UniProt
- P29590
-
Pathways
- Signalisation p53, Retinoic Acid Receptor Signaling Pathway, Maintenance of Protein Location, Positive Regulation of Endopeptidase Activity, Protein targeting to Nucleus
Antigène
-